vs
美泰（MAT）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
美泰的季度营收约是Steris的1.2倍（$1.8B vs $1.5B），Steris净利率更高（12.9% vs 6.0%，领先6.9%），Steris同比增速更快（9.2% vs 7.3%），过去两年美泰的营收复合增速更高（47.7% vs 15.8%）
美泰是美国知名玩具及娱乐企业，旗下影视制作部门美泰影业运营时间为2018年9月6日至2025年6月2日。其前身为2013年10月16日成立的美泰Playground Productions，更早可追溯至美泰娱乐、美泰工作室等集团原有娱乐业务品牌。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
MAT vs STE — 直观对比
营收规模更大
MAT
是对方的1.2倍
$1.5B
营收增速更快
STE
高出1.9%
7.3%
净利率更高
STE
高出6.9%
6.0%
两年增速更快
MAT
近两年复合增速
15.8%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $1.5B |
| 净利润 | $106.2M | $192.9M |
| 毛利率 | 45.9% | 43.8% |
| 营业利润率 | 8.0% | 18.3% |
| 净利率 | 6.0% | 12.9% |
| 营收同比 | 7.3% | 9.2% |
| 净利润同比 | -24.6% | 11.2% |
| 每股收益（稀释后） | $0.32 | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MATSTE
| Q4 25 | $1.8B | $1.5B | ||
| Q3 25 | $1.7B | $1.5B | ||
| Q2 25 | $1.0B | $1.4B | ||
| Q1 25 | $826.6M | $1.5B | ||
| Q4 24 | $1.6B | $1.4B | ||
| Q3 24 | $1.8B | $1.3B | ||
| Q2 24 | $1.1B | $1.3B | ||
| Q1 24 | $809.5M | $1.1B |
净利润MATSTE
| Q4 25 | $106.2M | $192.9M | ||
| Q3 25 | $278.4M | $191.9M | ||
| Q2 25 | $53.4M | $177.4M | ||
| Q1 25 | $-40.3M | $145.7M | ||
| Q4 24 | $140.9M | $173.5M | ||
| Q3 24 | $372.4M | $150.0M | ||
| Q2 24 | $56.9M | $145.4M | ||
| Q1 24 | $-28.3M | $-1.4M |
毛利率MATSTE
| Q4 25 | 45.9% | 43.8% | ||
| Q3 25 | 50.0% | 44.2% | ||
| Q2 25 | 50.9% | 45.1% | ||
| Q1 25 | 49.4% | 43.3% | ||
| Q4 24 | 50.7% | 44.5% | ||
| Q3 24 | 53.1% | 43.6% | ||
| Q2 24 | 49.2% | 44.7% | ||
| Q1 24 | 48.0% | 40.2% |
营业利润率MATSTE
| Q4 25 | 8.0% | 18.3% | ||
| Q3 25 | 21.9% | 18.2% | ||
| Q2 25 | 7.7% | 17.7% | ||
| Q1 25 | -6.4% | 14.6% | ||
| Q4 24 | 9.6% | 17.9% | ||
| Q3 24 | 26.5% | 16.5% | ||
| Q2 24 | 7.7% | 14.5% | ||
| Q1 24 | -4.4% | 22.0% |
净利率MATSTE
| Q4 25 | 6.0% | 12.9% | ||
| Q3 25 | 16.0% | 13.1% | ||
| Q2 25 | 5.2% | 12.8% | ||
| Q1 25 | -4.9% | 9.8% | ||
| Q4 24 | 8.6% | 12.7% | ||
| Q3 24 | 20.2% | 11.3% | ||
| Q2 24 | 5.3% | 11.4% | ||
| Q1 24 | -3.5% | -0.1% |
每股收益（稀释后）MATSTE
| Q4 25 | $0.32 | $1.96 | ||
| Q3 25 | $0.88 | $1.94 | ||
| Q2 25 | $0.16 | $1.79 | ||
| Q1 25 | $-0.12 | $1.48 | ||
| Q4 24 | $0.40 | $1.75 | ||
| Q3 24 | $1.09 | $1.51 | ||
| Q2 24 | $0.17 | $1.46 | ||
| Q1 24 | $-0.08 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $423.7M |
| 总债务越低越好 | $2.3B | $1.9B |
| 股东权益账面价值 | $2.2B | $7.2B |
| 总资产 | $6.6B | $10.6B |
| 负债/权益比越低杠杆越低 | 1.04× | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资MATSTE
| Q4 25 | $1.2B | $423.7M | ||
| Q3 25 | $691.9M | $319.2M | ||
| Q2 25 | $870.5M | $279.7M | ||
| Q1 25 | $1.2B | $171.7M | ||
| Q4 24 | $1.4B | $155.2M | ||
| Q3 24 | $723.5M | $172.2M | ||
| Q2 24 | $722.4M | $198.3M | ||
| Q1 24 | $1.1B | $207.0M |
总债务MATSTE
| Q4 25 | $2.3B | $1.9B | ||
| Q3 25 | $2.3B | $1.9B | ||
| Q2 25 | $2.3B | $1.9B | ||
| Q1 25 | $2.3B | $1.9B | ||
| Q4 24 | $2.3B | $2.0B | ||
| Q3 24 | $2.3B | $2.2B | ||
| Q2 24 | $2.3B | $2.2B | ||
| Q1 24 | $2.3B | $3.1B |
股东权益MATSTE
| Q4 25 | $2.2B | $7.2B | ||
| Q3 25 | $2.3B | $7.0B | ||
| Q2 25 | $2.2B | $7.0B | ||
| Q1 25 | $2.1B | $6.6B | ||
| Q4 24 | $2.3B | $6.4B | ||
| Q3 24 | $2.3B | $6.6B | ||
| Q2 24 | $2.0B | $6.4B | ||
| Q1 24 | $2.0B | $6.3B |
总资产MATSTE
| Q4 25 | $6.6B | $10.6B | ||
| Q3 25 | $6.6B | $10.4B | ||
| Q2 25 | $6.2B | $10.4B | ||
| Q1 25 | $6.2B | $10.1B | ||
| Q4 24 | $6.5B | $10.0B | ||
| Q3 24 | $6.5B | $10.2B | ||
| Q2 24 | $5.9B | $10.1B | ||
| Q1 24 | $6.1B | $11.1B |
负债/权益比MATSTE
| Q4 25 | 1.04× | 0.27× | ||
| Q3 25 | 1.03× | 0.27× | ||
| Q2 25 | 1.08× | 0.27× | ||
| Q1 25 | 1.10× | 0.29× | ||
| Q4 24 | 1.03× | 0.32× | ||
| Q3 24 | 1.01× | 0.33× | ||
| Q2 24 | 1.18× | 0.35× | ||
| Q1 24 | 1.15× | 0.50× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $796.6M | $298.2M |
| 自由现金流经营现金流 - 资本支出 | — | $199.5M |
| 自由现金流率自由现金流/营收 | — | 13.3% |
| 资本支出强度资本支出/营收 | — | 6.6% |
| 现金转化率经营现金流/净利润 | 7.50× | 1.55× |
| 过去12个月自由现金流最近4个季度 | — | $917.1M |
8季度趋势，按日历期对齐
经营现金流MATSTE
| Q4 25 | $796.6M | $298.2M | ||
| Q3 25 | $72.0M | $287.8M | ||
| Q2 25 | $-300.1M | $420.0M | ||
| Q1 25 | $24.8M | $260.8M | ||
| Q4 24 | $862.1M | $332.8M | ||
| Q3 24 | $155.8M | $250.7M | ||
| Q2 24 | $-252.9M | $303.7M | ||
| Q1 24 | $35.5M | $254.8M |
自由现金流MATSTE
| Q4 25 | — | $199.5M | ||
| Q3 25 | — | $201.3M | ||
| Q2 25 | — | $326.4M | ||
| Q1 25 | — | $189.9M | ||
| Q4 24 | — | $243.6M | ||
| Q3 24 | — | $148.8M | ||
| Q2 24 | — | $195.7M | ||
| Q1 24 | — | $163.3M |
自由现金流率MATSTE
| Q4 25 | — | 13.3% | ||
| Q3 25 | — | 13.8% | ||
| Q2 25 | — | 23.5% | ||
| Q1 25 | — | 12.8% | ||
| Q4 24 | — | 17.8% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | — | 15.3% | ||
| Q1 24 | — | 14.6% |
资本支出强度MATSTE
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | 5.9% | ||
| Q2 25 | — | 6.7% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | — | 8.2% |
现金转化率MATSTE
| Q4 25 | 7.50× | 1.55× | ||
| Q3 25 | 0.26× | 1.50× | ||
| Q2 25 | -5.62× | 2.37× | ||
| Q1 25 | — | 1.79× | ||
| Q4 24 | 6.12× | 1.92× | ||
| Q3 24 | 0.42× | 1.67× | ||
| Q2 24 | -4.45× | 2.09× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MAT
| North America Segment | $1.0B | 58% |
| International Segment | $745.6M | 42% |
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
